BUR1 Antibody

What is BUR1 and how does it function in cellular processes?

BUR1 is an essential cyclin-dependent kinase (CDK) in Saccharomyces cerevisiae that forms a complex with its cyclin partner BUR2. This kinase plays crucial roles in transcriptional regulation and cell cycle control. BUR1 regulates transcription elongation through phosphorylation of the C-terminal domain (CTD) of RNA polymerase II . Additionally, BUR1 participates in cell cycle progression, particularly during the G1-to-S phase transition . Beyond its well-characterized function in transcription, BUR1 has been recently implicated in the TORC1 signaling pathway, directly phosphorylating Sch9, a known target of TORC1 . This multi-functional kinase has a typical CDK domain and an extended C-terminal region that, while not essential for growth under normal conditions, becomes important under cellular stress .

How do I distinguish between BUR1 and BubR1/BUB1B when selecting antibodies?

Despite similar nomenclature, BUR1 and BubR1/BUB1B are distinct proteins with different cellular functions and organism specificity:

When selecting antibodies, verify the target organism and confirm specificity through sequence analysis and validation data. For yeast studies, ensure the antibody specifically recognizes BUR1 rather than the mammalian BubR1/BUB1B protein .

What experimental applications are supported by BUR1 antibodies?

BUR1 antibodies support multiple experimental applications in yeast research:

• Western blotting: Detection of BUR1 protein levels in cell lysates to assess expression changes under different conditions or in mutant strains .

• Immunoprecipitation (IP): Isolation of BUR1 and associated proteins for interaction studies or downstream kinase assays .

• Chromatin Immunoprecipitation (ChIP): Analysis of BUR1 occupancy on chromatin to study its association with specific gene regions during transcription. ChIP experiments demonstrate that Bur1 and Bur2 cross-link to coding regions in a transcription-dependent manner .

• Immunofluorescence (IF): Visualization of BUR1 subcellular localization during different cell cycle stages or stress conditions.

For optimal results in each application, antibody selection should be based on validated performance in the specific application of interest, with appropriate controls included to ensure specificity and reproducibility.

How should I design controls for BUR1 antibody validation?

Proper antibody validation requires multiple control strategies:

• Genetic controls:

  • Use BUR1 deletion strains (where viable) or temperature-sensitive mutants as negative controls

  • Compare wild-type with strains expressing mutant versions (e.g., kinase-dead variants)

  • Utilize epitope-tagged BUR1 strains to confirm antibody specificity

• Biochemical controls:

  • Peptide competition assays to demonstrate specificity

  • Phosphatase treatment when studying phosphorylated forms

  • Recombinant protein standards for band identification

• Technical controls:

  • Include isotype controls for immunoprecipitation experiments

  • Use secondary-only controls for immunofluorescence

  • Prepare mock IP samples as background controls

Validation should be performed for each experimental application, as an antibody may perform well in Western blotting but poorly in ChIP or immunofluorescence.

What are the optimal sample preparation conditions for BUR1 detection in yeast?

For reliable BUR1 detection in yeast samples, consider these preparation guidelines:

• Cell growth and harvesting:

  • Harvest cells in mid-logarithmic phase (OD600 0.6-0.8) for consistent BUR1 expression

  • Rapidly cool cultures on ice to prevent protein modifications during processing

  • Consider synchronizing cultures if studying cell-cycle dependent changes

• Protein extraction methods:

  • For Western blotting: TCA precipitation or glass bead lysis with protease inhibitors

  • For immunoprecipitation: Gentler lysis conditions to preserve protein-protein interactions

  • For ChIP: Formaldehyde crosslinking (typically 1-3%) before cell lysis

• Buffer composition:

  • Include protease inhibitors (PMSF, leupeptin, pepstatin)

  • Add phosphatase inhibitors when studying phosphorylation status

  • Optimize salt concentration to maintain specific interactions

• Storage considerations:

  • Prepare fresh extracts when possible

  • For storage, flash-freeze aliquots and store at -80°C

  • Avoid multiple freeze-thaw cycles

Proper sample preparation is critical for preserving BUR1 integrity and interactions, particularly when studying dynamic processes like transcription elongation and cell cycle progression .

How can I optimize ChIP protocols for studying BUR1 chromatin association?

Chromatin immunoprecipitation for BUR1 requires specific optimization:

• Crosslinking conditions:

  • Test formaldehyde concentrations (1-3%) and times (10-20 minutes)

  • Quench with glycine to stop crosslinking

• Chromatin shearing:

  • Optimize sonication for 200-500bp fragments

  • Verify fragment size by gel electrophoresis before proceeding

• Antibody selection:

  • Choose antibodies validated for ChIP applications

  • Consider epitope-tagged BUR1 with anti-tag antibodies for higher specificity

  • Use proper antibody amounts (typically 2-5μg per IP)

• Critical controls:

  • Input chromatin sample (pre-immunoprecipitation)

  • IgG or pre-immune serum control

  • Positive control regions (genes known to be bound by BUR1)

  • BUR1 temperature-sensitive mutants as negative controls

• Analysis strategies:

  • Design primers for promoter regions, early coding regions, and 3' regions

  • Consider that BUR1 chromatin association drops after RNA polymerase II transcribes through polyadenylation sites

For genome-wide analysis, ChIP-seq provides comprehensive mapping of BUR1 occupancy patterns across the genome, revealing association with actively transcribed genes.

What approaches can identify BUR1 protein-protein interactions in vivo?

To identify and characterize BUR1 protein interactions:

• Co-immunoprecipitation (Co-IP):

  • Use BUR1 antibodies to pull down protein complexes

  • Analyze by Western blot for known interactors or mass spectrometry for unbiased discovery

  • Include appropriate controls (IgG, pre-immune serum)

• Proximity-based labeling:

  • BioID or APEX2 fusions to BUR1 to identify proteins in close proximity

  • TurboID for faster labeling kinetics in time-sensitive applications

• Genetic approaches:

  • Synthetic genetic array (SGA) analysis to identify functional interactions

  • Suppressor screens to identify genes that mitigate BUR1 mutant phenotypes

  • Two-hybrid screens for direct protein-protein interactions

• Crosslinking strategies:

  • In vivo crosslinking followed by mass spectrometry

  • Site-specific crosslinkers to identify interaction interfaces

Research shows that Bur1 and its cyclin partner Bur2 are recruited to transcription elongation complexes, cross-linking to coding regions of genes in a manner dependent upon transcription . This indicates physical association with the transcription machinery.

How should I design experiments to study BUR1's role in cell cycle progression?

To investigate BUR1's cell cycle functions:

• Synchronization approaches:

  • Alpha-factor arrest-release for G1 synchronization

  • Hydroxyurea treatment for S-phase arrest

  • Analyze synchronized populations at regular intervals after release

• Cell cycle markers:

  • Flow cytometry with propidium iodide staining for DNA content

  • Whi5 nuclear localization to monitor G1/S transition

  • Bud morphology analysis

  • Cyclin expression patterns

• Genetic strategies:

  • Temperature-sensitive BUR1 mutants for conditional inactivation

  • Analyze synthetic interactions with known cell cycle regulators

  • Test suppressor relationships with checkpoint genes

• Stress response connections:

  • Examine BUR1's role during replication stress (hydroxyurea treatment)

  • Analyze checkpoint activation in BUR1 mutants

  • Study genetic interactions with checkpoint kinases MEC1 and RAD53

Research indicates that BUR1 drives G1-to-S phase transition, and BUR1 mutations (bur1-107) delay this transition . Additionally, BUR1 functions with TORC1 for vacuole-mediated cell cycle progression, showing that multiple signals converge on Sch9 to promote cell cycle progression .

How can I assess BUR1 kinase activity in different experimental contexts?

To measure BUR1 kinase activity:

• In vitro kinase assays:

  • Immunoprecipitate BUR1 from yeast extracts

  • Incubate with purified substrates (e.g., RNA Pol II CTD peptides)

  • Detect phosphorylation by autoradiography or phospho-specific antibodies

  • Include kinase-dead mutants (E107Q, D213A) as negative controls

• Phospho-substrate monitoring:

  • Analyze phosphorylation of known BUR1 substrates (RNA Pol II CTD, Sch9)

  • Use phospho-specific antibodies for Western blotting

  • Compare wild-type with BUR1 mutant strains

• Genetic approaches:

  • Analyze phenotypes of phospho-site mutants in substrates

  • Test epistatic relationships between BUR1 and substrate mutants

  • Use analog-sensitive BUR1 mutants for specific chemical inhibition

• Cellular readouts:

  • Monitor transcriptional output of BUR1-dependent genes

  • Assess cell cycle progression as a function of BUR1 activity

  • Evaluate resistance to stressors like hydroxyurea or 6-azauracil

Research demonstrates that BUR1 kinase activity is essential for its cellular functions, and mutations that disrupt this activity lead to specific phenotypic patterns .

What strategies help differentiate between BUR1's transcriptional and cell cycle functions?

Distinguishing between BUR1's transcriptional and cell cycle roles:

• Domain-specific mutations:

  • Kinase domain mutations affect all functions

  • C-terminal mutations may selectively impact certain functions

  • T-loop phosphorylation site mutants (T240A, T240D) affect activation state

• Substrate specificity:

  • RNA Pol II CTD phosphorylation reflects transcriptional function

  • Sch9 phosphorylation indicates cell cycle regulatory function

  • Compare phosphorylation patterns of different substrates

• Genetic approaches:

  • Test rescue of different phenotypes with domain-specific mutants

  • Analyze genetic interactions with transcription versus cell cycle factors

  • Create separation-of-function mutations through targeted mutagenesis

• Temporal analysis:

  • Monitor BUR1 activity throughout the cell cycle

  • Compare timing of transcriptional effects versus cell cycle transitions

  • Use rapid inactivation techniques to determine immediate versus secondary effects

Research shows that BUR1 has separable roles mediated by different domains. The kinase domain is essential for all functions, while the C-terminal region and T-loop phosphorylation contribute to distinct aspects of BUR1 activity .

How can I analyze BUR1 phosphorylation states and their functional significance?

To study BUR1 phosphorylation:

• Detection methods:

  • Phospho-specific antibodies against known sites (e.g., T-loop)

  • Phos-tag SDS-PAGE to separate phosphorylated species

  • Mass spectrometry for comprehensive phosphorylation site mapping

• Functional analysis:

  • Compare wild-type BUR1 with phospho-site mutants:

    • Alanine mutants (non-phosphorylatable)

    • Aspartate/glutamate mutants (phosphomimetic)

  • Assess phenotypes across conditions (normal growth, stress)

  • Evaluate impact on kinase activity and protein interactions

• Regulatory mechanisms:

  • Identify upstream kinases responsible for BUR1 phosphorylation

  • Study cell cycle-dependence of phosphorylation patterns

  • Analyze effects of phosphatase inhibitors/activators

• Structural considerations:

  • Model how phosphorylation impacts protein conformation

  • Study effects on protein stability and turnover

  • Examine changes in subcellular localization

Research indicates that T-loop phosphorylation affects BUR1 function but is not absolutely essential, suggesting regulatory rather than obligatory roles for certain phosphorylation events .

What approaches help resolve contradictory findings in BUR1 research?

When facing contradictory results:

• Strain background considerations:

  • Different yeast strains may show variable BUR1 phenotypes

  • Document complete genotypes of all strains used

  • Test key findings in multiple genetic backgrounds

• Methodological variables:

  • Compare extraction protocols (native vs. denaturing)

  • Standardize growth conditions (media, temperature, phase)

  • Examine antibody specificity across applications

• Reconciliation strategies:

  • Perform epistasis analysis to determine pathway relationships

  • Test condition-specificity of contradictory findings

  • Design experiments that directly test competing hypotheses

• Statistical rigor:

  • Increase biological and technical replicates

  • Apply appropriate statistical tests

  • Calculate effect sizes to quantify biological significance

• Integrated approaches:

  • Combine genetic, biochemical, and cell biological methods

  • Use orthogonal techniques to verify key findings

  • Consider time-dependent or context-dependent effects

When evaluating contradictory findings, consider that BUR1 functions in multiple pathways and its roles may vary with cellular context. For example, hypomorphic BUR1 alleles (bur1-107) suppress hydroxyurea sensitivity in checkpoint mutants, suggesting context-dependent functions .

How should I interpret BUR1 localization changes during stress responses?

Interpreting BUR1 localization during stress:

• Context-specific analysis:

  • Different stressors may trigger distinct BUR1 responses

  • Consider time course data (acute vs. adaptive responses)

  • Correlate localization with functional outcomes

• Common patterns and interpretations:

  • Increased chromatin association: Enhanced transcriptional regulation role

  • Relocalization within nucleus: Shift in target gene regulation

  • Altered nuclear/cytoplasmic distribution: Regulatory mechanism

• Integration with other pathways:

  • TORC1 pathway crosstalk during nutrient stress

  • DNA damage response during replication stress

  • General stress response pathways

• Functional validation:

  • Test if preventing localization changes alters stress responses

  • Correlate localization patterns with substrate phosphorylation

  • Compare wild-type with mutant proteins unable to undergo localization changes

Research shows that BUR1 plays crucial roles during replication stress. The bur1-107 allele suppresses hydroxyurea sensitivity in checkpoint-deficient cells, suggesting BUR1-driven G1-to-S phase progression may exacerbate DNA damage in these contexts .

What statistical approaches are appropriate for analyzing BUR1 ChIP-seq data?

For robust ChIP-seq analysis:

• Quality control metrics:

  • Fragment size distribution analysis

  • Library complexity assessment

  • Cross-correlation analysis

  • Signal-to-noise ratio evaluation

• Peak calling strategies:

  • Select appropriate algorithms (MACS2, HOMER, etc.)

  • Use input controls for background normalization

  • Set false discovery rate thresholds (typically FDR < 0.05)

• Comparative analyses:

  • Differential binding analysis between conditions

  • Integration with transcriptomic data

  • Comparison with other factors (RNA Pol II, histone marks)

• Functional enrichment:

  • Gene Ontology analysis of BUR1-bound genes

  • Motif enrichment analysis for co-factor binding sites

  • Pathway analysis of regulated genes

• Advanced visualization:

  • Profile plots showing distribution around genomic features

  • Heat maps for comparing multiple datasets

  • Genome browser tracks for specific locus examination

When interpreting BUR1 ChIP-seq data, consider that BUR1 cross-linking to coding regions depends on transcription but not on BUR1 kinase activity. Additionally, BUR1 cross-linking decreases after RNA polymerase II transcribes through polyadenylation sites .

How can I design experiments to explore BUR1's role at the intersection of transcription and cell cycle control?

To investigate BUR1's dual functions:

• Temporal coordination studies:

  • Analyze BUR1 activity throughout synchronized cell cycles

  • Monitor transcription of cell cycle genes in BUR1 mutants

  • Track cell cycle progression in response to transcriptional inhibitors

• Substrate-specific approaches:

  • Create separation-of-function mutants affecting specific substrates

  • Monitor phosphorylation of transcriptional versus cell cycle substrates

  • Use phospho-proteomic analysis to identify substrate networks

• Pathway integration experiments:

  • Study BUR1 in relation to TORC1 signaling under different growth conditions

  • Analyze connections with DNA damage response pathways

  • Examine interactions with cell cycle checkpoint mechanisms

• Synthetic genetic approaches:

  • Perform genetic screens for differential suppression of transcriptional versus cell cycle phenotypes

  • Create double mutants with specific transcription or cell cycle factors

  • Test for genetic interactions with vacuole inheritance mutants

Recent research demonstrates that BUR1 functions with TORC1 for vacuole-mediated cell cycle progression and directly phosphorylates Sch9, revealing how multiple signals converge to promote cell cycle progression .

What are the current limitations in BUR1 antibody technology and how might they be addressed?

Current limitations and potential solutions:

• Specificity challenges:

  • Cross-reactivity with related CDKs

  • Epitope masking by protein interactions or modifications

  • Limited validation across applications

  Solutions:

  • Develop monoclonal antibodies against unique BUR1 regions

  • Validate with CRISPR/gene editing controls

  • Create application-specific validation standards

• Phospho-specific detection:

  • Limited availability of site-specific phospho-antibodies

  • Variable performance across experimental conditions

  • Challenges in quantitative analysis

  Solutions:

  • Generate antibodies against key regulatory phosphorylation sites

  • Develop multiplexed detection methods for multiple modifications

  • Establish quantitative standards for phosphorylation analysis

• Cross-species applications:

  • Variability in epitope conservation across yeast species

  • Limited validation beyond S. cerevisiae

  • Species-specific optimization requirements

  Solutions:

  • Design antibodies against conserved regions for cross-species use

  • Validate systematically across yeast species

  • Create species-specific validation standards

• Future technologies:

  • Nanobodies for improved access to structured epitopes

  • Split-fluorescent protein tagging for live-cell visualization

  • Proximity labeling approaches for interaction studies

Addressing these limitations will enhance our ability to study BUR1 functions across diverse experimental contexts and model systems.

What emerging research directions are developing in BUR1 biology?

Several promising research avenues are emerging:

• Systems-level integration:

  • Network analysis of BUR1 in transcriptional and cell cycle regulation

  • Mathematical modeling of BUR1 activity in multiple pathways

  • Single-cell approaches to capture cell-to-cell variability

• Evolutionary perspectives:

  • Comparative analysis across fungal species

  • Examination of functional conservation with mammalian CDK9

  • Evolutionary adaptation of regulatory mechanisms

• Stress response mechanisms:

  • BUR1's role during replication stress and DNA damage

  • Functions in nutrient sensing and TORC1 signaling

  • Connections to cellular adaptation and survival

• Therapeutic relevance:

  • BUR1 as a model for understanding CDK inhibitor mechanisms

  • Targeting transcription-coupled cell cycle regulation

  • Implications for antifungal development

Recent discoveries highlighting BUR1's role in cell cycle progression and its interactions with checkpoint kinases open new avenues for understanding how cells coordinate transcription, cell cycle progression, and stress responses .

How can BUR1 research inform our understanding of related kinases in higher eukaryotes?

BUR1 research provides valuable insights for higher eukaryotes:

• CDK9 connections:

  • BUR1 is considered a functional ortholog of mammalian CDK9

  • Shared roles in transcriptional elongation

  • Conservation of regulatory mechanisms and substrates

• Translational implications:

  • Insights into transcription-coupled cell cycle regulation

  • Understanding of kinase-substrate networks

  • Models for CDK inhibitor development and specificity

• Disease relevance:

  • CDK9 is implicated in cancer, cardiac hypertrophy, and viral infections

  • BUR1 research may reveal conserved vulnerability points

  • Therapeutic targeting strategies based on mechanistic insights

• Evolutionary conservation:

  • Core functions preserved from yeast to humans

  • Lineage-specific adaptations and specializations

  • Divergence and convergence of regulatory circuits

Understanding BUR1's dual roles in transcription elongation and cell cycle control provides a valuable model for studying how these processes are coordinated across eukaryotes, with potential implications for disease treatment and cellular engineering.